Skip to main content
Premium Trial:

Request an Annual Quote

Promega Becomes First in Line For WARF Technology

NEW YORK, Sept. 28 (GenomeWeb News) - Promega will become the first company to be allowed easy access and expedited technology licenses through a new offering from the Wisconsin Alumni Research Foundation, Promega and WARF said yesterday.

 

WARF is making it easier for companies to licence technology developed at the University of Wisconsin, Madison, through its Research Tool Subscription Program. As the first company to access the technology through the program, Promega will  have "an easier path to licensing technologies" and "can provide new products to life scientists sooner," Randy Dimond, Promega's chief technical officer, said in a statement.

 

The life sciences firm is also based in Madison.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.